Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
OwnerElizabeth Nabel, Gary Nabel +1inventors
InventorsElizabeth Nabel, Gary Nabel, Zhi-yong Yang
Life of this patent
Estimating the term…
Abstract
The present invention describes DNA coated stents and methods of using the same to treat or prevent vascular diseases, such as restenosis.
Claims37
1-20. Cancelled
A method for expressing therapeutically useful amounts of recombinant genes in vivo, comprising the step of placing an implantable device into the vasculature of a patient, wherein the device comprises a biostable intravascular stent coated with a polymer matrix and DNA encoding a therapeutically useful protein, said DNA being uniformly-dispersed within said matrix.
A method for treating or preventing a vascular disease, comprising the step of placing an implantable device into the vasculature of a patient, wherein the device comprises a biostable intravascular stent coated with a polymer matrix and DNA encoding a protein therapeutically useful for treating the vascular disease, said DNA being uniformly dispersed within said matrix.
A method for expressing therapeutically useful amounts of recombinant genes in vivo, comprising the step of placing an implantable device into the vasculature of a patient, wherein the device comprises a biostable intravascular stent coated with a polymer matrix and DNA encoding a therapeutically useful protein, said DNA being in contact with said matrix.
Dependencies are inferred from the claim text.